Pfs48/45 central and C-terminal domains bound to Fab fragments of monoclonal antibody 10D8 and 32F3

1-Gaussian fit: Grosse-Kunstleve RW, Sauter NK, Adams PD: Newsletter of the IUCr Commission on Crystallographic Computing 2004, 3, 22-31.

alpha-L-fucose; 6-deoxy-alpha-L-galactopyranose; L-fucose; fucose

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.

MMLYISAKKAQVAFILYIVLVLRIISGNNDFCKPSSLNSEISGFIGYKCNFSNEGVHNLKPDMRERRSIFCTIHSYFIYD
KIRLIIPKKSSSPEFKILPEKCFQKVYTDYENRVETDISELGLIEYEIEENDTNPNYNERTITISPFSPKDIEFFCFCDN
TEKVISSIEGRSAMVHVRVLKYPHNILFTNLTNDLFTYLPKTYNESNFVSNVLEVELNDGELFVLACELINKKCFQEGKE
KALYKSNKIIYHKNLTIFKAPFYVTSKDVNTECTCKFKNNNYKIVLKPKYEKKVIHGCNFSSNVSSKHTFTDSLDISLVD
DSAHISCNVHLSEPKYNHLVGLNCPGDIIPDCFFQVYQPESEELEPSNIVYLDSQINIGDIEYYEDAEGDDKIKLFGIVG
SIPKTTSFTCICKKDKKSAYMTVTIDSA

DVKLVESGGGLVKLGGSLKLSCAASGFTFSSYYMSWVRQTPEKRLELVAAINNNGGSTYYPDTVKGRFTISRDNAKNTLN
LQMNSLKSEDTALYYCTRQHYGNLYFFDYWGQGTTLTVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVT
WNSGSLSSGVHTFPAVLESDLYTLSSSVTVPSSPWPSETVTCNVAHPASSTKVDKKIVPRDCGCKPCICTVPEVSSVFIF
PPKPKDVLTITLTPKVTCVVVDISKDDPEVQFSWFVDDVEVHTAQTQPREEQFNSTFRSVSELPIMHQDWLNGKEFKCRV
NSAAFPAPIEKTISKTKGRPKAPQVYTIPPPKEQMAKDKVSLTCMITDFFPEDITVEWQWNGQPAENYKNTQPIMNTNGS
YFVYSKLNVQKSNWEAGNTFTCSVLHEGLHNHHTEKSLSHSPGK

QIVLSQSPAILSASPGEKVTMTCRASSSVTYIHWYQQKPGSSPKPWIQATSSLASGVPARFSGSGSGTSYSLSISRVEAE
DAATYYCQQWSSNPLTFGAGTKLELKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLN
SWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC

MNFGLSLIFLVLVLKGVQCEVMLVESGGDLVKPGGSLKVSCAASGFTFSNYAMSWVRQTPEKRLEWVATISSGASYTHYP
DSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCGRQVNRHDRALDAMDYWGQGTSVTVSPAKTTPPSVYPLAPGSAAQ
TNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIV
PRDCGCKPCICTVPEVSSVFIFPPKPKDVLTITLTPKVTCVVVDISKDDPEVQFSWFVDDVEVHTAQTQPREEQFNSTFR
SVSELPIMHQDWLNGKEFKCRVNSAAFPAPIEKTISKTKGRPKAPQVYTIPPPKEQMAKDKVSLTCMITDFFPEDITVEW
QWNGQPAENYKNTQPIMDTDGSYFVYSKLNVQKSNWEAGNTFTCSVLHEGLHNHHTEKSLSHSPGK

MDSQAQVLMLLLLWVSGTCGDIVMSQSPSSLAVSVGEKVTMSCKSSQSLFYSSNQKNYLAWYQQKPGQSPKLLIYWASTR
ESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPPTFGGGTKLEIKRADAAPTVSIFPPSSEQLTSGGASVVC
FLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC

10 % (w/v) PEG monomethyl ether 5000, 0.1M 2-(N-morpholino) ethanesulfonic acid pH 6.5 and 12% (v/v) 1-propanol

Medical Research Council (MRC, United Kingdom)

Pfs48/45, malaria, transmission-blocking, Plasmodium falciparum, gamete, antibody, CELL ADHESION
(chain "D" and (resid 2 or resid 4 through 88 or resid 90 through 124 or resid 126 through 168 or resid 170 through 181 or resid 184 through 214 or resid 216 through 222))
(chain "I" and (resid 2 or resid 4 through 88 or resid 90 through 124 or resid 126 through 136 or resid 145 through 168 or resid 170 through 181 or resid 184 through 214 or resid 216 through 222))
(chain "E" and (resid 2 through 30 or resid 32 through 108 or resid 110 or resid 112 or resid 114 through 147 or resid 149 through 161 or resid 163 through 174 or resid 176 through 204 or resid 206 through 217))
(chain "J" and (resid 2 through 30 or resid 32 through 108 or resid 110 or resid 112 or resid 114 through 147 or resid 149 through 161 or resid 163 through 174 or resid 176 through 204 or resid 206 through 217))